Healthcare

BioNxt Solutions has formally initiated the commercial phase for its sublingual drug delivery platform, marking a significant corporate milestone announced...

In a counterintuitive market reaction, Ocugen's stock price declined significantly following the announcement of encouraging 12-month data from its Phase...

A significant regulatory warning from the U.S. Food and Drug Administration (FDA) has triggered a sharp sell-off in ImmunityBio shares....

The American health insurance giant UnitedHealth Group is navigating a complex landscape of financial and regulatory challenges. In response to...

A surge in institutional buying activity is placing a traditional healthcare conglomerate firmly on the radar of major market players....

The healthcare technology company Evolent Health is making a strategic push into artificial intelligence, appointing a seasoned AI specialist to...

Lexaria Bioscience is positioning its proprietary DehydraTECH technology as a potential solution to a critical problem plaguing popular weight-loss and...

In a surprising market reaction, shares of biotechnology firm Ocugen experienced a significant sell-off this week, even as the company...

The regulatory landscape for UnitedHealth Group is intensifying on multiple fronts simultaneously. As the healthcare giant approaches its quarterly earnings...

HEALWELL AI Inc. has successfully completed its transformation into a pure-play technology company, a strategic shift that is now delivering...